Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NANO

Nanobiotix (NANO)

Nanobiotix
Date:
Sort by:
 Showing the most relevant articles for your search:EU:NANO
DateTimeSourceHeadlineSymbolCompany
07/10/20235:37PMDow Jones NewsADRs End Mostly Lower, Nanobiotix and Taiwan Semiconductor Manufacturing Trade ActivelyEU:NANONanobiotix
07/10/20236:37AMDow Jones NewsECHO BOURSE: Nanobiotix bondit de 51% après un accord de licence avec JanssenEU:NANONanobiotix
07/10/20235:57AMDow Jones NewsNanobiotix Shares Soar on Licensing Deal With J&J UnitEU:NANONanobiotix
05/05/202312:11PMDow Jones NewsECHO BOURSE: Nanobiotix en négociation avec un grand laboratoire, l'action s'envoleEU:NANONanobiotix
05/05/202312:06PMDow Jones NewsECHO BOURSE: Nanobiotix en négociation avec un grand laboratoire, l'action s'envoleEU:NANONanobiotix
07/09/20191:45PMGlobeNewswire Inc.Nanobiotix announces publication of phase III Soft Tissue Sarcoma data for first-in-class NBTXR3 in the Lancet OncologyEU:NANONanobiotix
07/01/20191:00AMGlobeNewswire Inc.Nanobiotix announces new organizational structure as the company enters its next stage after first european market approvalEU:NANONanobiotix
06/04/20191:00AMGlobeNewswire Inc.NANOBIOTIX APPOINTS NEW CHIEF MEDICAL OFFICER AS THE COMPANY EVOLVES AFTER ACHIEVEMENT OF EUROPEAN MARKET APPROVALEU:NANONanobiotix
05/28/201912:00AMGlobeNewswire Inc.Nanobiotix announces the launch of curadigm : a new nanotechnology platform for healthcareEU:NANONanobiotix
04/04/201911:31AMGlobeNewswire Inc.Nanobiotix Announces First Ever Radioenhancer to Receive European Market ApprovalEU:NANONanobiotix
04/02/201911:56AMGlobeNewswire Inc.Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pr...EU:NANONanobiotix
03/26/20192:00AMGlobeNewswire Inc.Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedbackEU:NANONanobiotix
03/15/201912:40PMGlobeNewswire Inc.Nanobiotix 2018 Annual ResultsEU:NANONanobiotix
11/15/20186:00AMGlobeNewswire Inc.Nanobiotix revenues for the 3rd quarter of 2018EU:NANONanobiotix
10/19/20187:05AMGlobeNewswire Inc.NANOBIOTIX: Positive phase II/III results for NBTXR3 in Soft Tissue Sarcoma presented at ESMOEU:NANONanobiotix
10/15/20189:13PMGlobeNewswire Inc.Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment BankEU:NANONanobiotix
09/25/20189:00PMGlobeNewswire Inc.Nanobiotix to present positive results from its phase II/III clinical trial of NBTXR3 in patients with Soft Tissue Sarcoma (S...EU:NANONanobiotix
09/19/20189:04PMGlobeNewswire Inc.Nanobiotix: Update on Head and Neck Phase I/II Trial with NBTXR3 and Other program data presented at ImmunoRad 2018EU:NANONanobiotix
09/04/201811:20AMGlobeNewswire Inc.NANOBIOTIX half year results for the six months ended June 30, 2018EU:NANONanobiotix
07/26/201811:32AMGlobeNewswire Inc.NANOBIOTIX signs a 40 M€ non-dilutive financing agreement with the European Investment BankEU:NANONanobiotix
06/22/20187:29AMDow Jones NewsNanobiotix offre un succès bienvenu pour relancer les biotechs tricolores - DJ PlusEU:NANONanobiotix
06/21/201812:41PMGlobeNewswire Inc.NANOBIOTIX announces positive phase II/III topline data in soft tissue sarcoma with NBTXR3EU:NANONanobiotix
06/06/20188:55AMGlobeNewswire Inc.NANOBIOTIX' Management statement on recent share price variationEU:NANONanobiotix
05/14/20181:57AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
05/03/201812:35PMGlobeNewswire Inc.Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathwa...EU:NANONanobiotix
04/17/20181:01PMGlobeNewswire Inc.AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING path...EU:NANONanobiotix
04/11/20182:01AMCercle FinanceNanobiotix: projet de recherche avec le MD AndersonEU:NANONanobiotix
04/10/20181:42PMGlobeNewswire Inc.NANOBIOTIX : THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER AND NANOBIOTIX HAVE AN AGREEMENT TO RUN IMMUNOTHERAPEUTIC PRE-...EU:NANONanobiotix
03/30/20189:03AMGlobeNewswire Inc.NANOBIOTIX : Nanobiotix 2017 Annual ResultsEU:NANONanobiotix
03/26/20182:12AMCercle FinanceCalendrier des sociétés sur 15 joursEU:NANONanobiotix
 Showing the most relevant articles for your search:EU:NANO